The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small c... by V V Ryazhenov

Get full text

Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene by V V Ryazhenov, S G Gorokhova

Get full text

Ispol'zovanie pokazatelya effektivnosti zatrat pri kompleksnoy farmakoekonomicheskoy otsenke dorogostoyashchikh meditsinskikh tekhnologiy. Primer bevatsizumaba by V V Ryazhenov, S G Gorokhova

Get full text

Analiz zabolevaemosti rakommolochnoy zhelezy s uchetom statusa HER2na territorii Rossiyskoy Federatsii by V V Ryazhenov, S G Gorokhova

Get full text

PHARMACOECONOMIC ANALYSIS OF OLMESARTAN THERAPY IN THE INDIVIDUAL–LEVEL MANAGEMENT OF ARTERIAL HYPERTENSION by S. G. Gorokhova, V. V. Ryazhenov

Get full text

Prognozirovanie zabolevaemosti rakom molochnoy zhelezy s vydeleniem populyatsii patsientov s giperekspressiey HER2 v Sibirskom federal'nom okruge by V V Ryazhenov, S G Gorokhova

Get full text

PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS by V. V. Ryazhenov, S. G. Gorokhova

Get full text

RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research by V. V. Ryazhenov, S. G. Gorokhova, N. D. Bunyatyan

Get full text

Pharmacoeconomic analysis of the use of actovegin in patients with post-stroke cognitive impairment in the health care system of the Russian Federation by V. V. Ryazhenov, S. G. Gorokhova, A. V. Knyazev

Get full text